M. C. Abt, L. C. Osborne, L. A. Monticelli, T. A. Doering, T. Alenghat et al., , 2012.

, Commensal bacteria calibrate the activation threshold of innate antiviral immunity, Immunity, vol.37, pp.158-170

A. Agus, J. Planchais, and H. Sokol, Gut microbiota regulation of tryptophan metabolism in health and disease, Cell Host Microbe, vol.23, pp.716-724, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01821219

K. H. Antunes, J. L. Fachi, R. De-paula, E. F. Da-silva, L. P. Pral et al., , 2019.

, Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response, Nat. Commun, vol.10, pp.3273-3289

A. Badawi, R. Velummailum, S. G. Ryoo, A. Senthinathan, S. Yaghoubi et al., Prevalence of chronic comorbidities in dengue fever and West Nile virus: A systematic review and meta-analysis, PLoS ONE, vol.13, 2018.

J. M. Blander, R. S. Longman, I. D. Iliev, G. F. Sonnenberg, and D. Artis, Regulation of inflammation by microbiota interactions with the host, Nat. Immunol, vol.18, pp.851-860, 2017.

K. C. Bradley, K. Finsterbusch, D. Schnepf, S. Crotta, M. Llorian et al., Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection, Cell Rep, vol.28, pp.245-256, 2019.

E. Callaway, Labs rush to study coronavirus in transgenic animalssome are in short supply, Nature, vol.579, p.183, 2020.

A. Cavezzi, E. Troiani, and S. Corrao, COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review, Clin. Pract, vol.10, pp.1271-1277, 2020.

G. Chen, D. Wu, W. Guo, Y. Cao, D. Huang et al., Clinical and immunological features of severe and moderate coronavirus disease 2019, J. Clin. Invest, vol.130, pp.2620-2629, 2020.

K. S. Cheung, I. F. Hung, P. P. Chan, K. C. Lung, E. Tso et al., Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis, Gastroenterology, 2020.

B. Coutard, C. Valle, X. De-lamballerie, B. Canard, N. G. Seidah et al., The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade, Antiviral Res, vol.176, pp.104742-104746, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02890592

M. A. Crackower, R. Sarao, G. Y. Oudit, C. Yagil, I. Kozieradzki et al., , 2002.

, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, vol.417, pp.822-828

E. Deriu, G. M. Boxx, X. He, C. Pan, S. D. Benavidez et al., Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through type I interferons, PLoS Pathog, vol.12, p.1005572, 2016.

M. Effenberger, F. Grabherr, L. Mayr, J. Schwaerzler, M. Nairz et al., Faecal calprotectin indicates intestinal inflammation in COVID-19, Gut, 2020.

A. R. Fehr, R. Channappanavar, and S. Perlman, Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus, Annu. Rev. Med, vol.68, pp.387-399, 2017.

M. Gheblawi, K. Wang, A. Viveiros, Q. Nguyen, J. C. Zhong et al., Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ACE2, Circ. Res, vol.126, pp.1456-1474, 2020.

H. T. Groves, L. Cuthbertson, P. James, M. F. Moffatt, M. J. Cox et al., Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota, Front. Immunol, vol.9, pp.182-193, 2018.

S. Gu, Y. Chen, Z. Wu, Y. Chen, H. Gao et al., Alterations of the gut microbiota in patients with COVID-19 or H1N1 Influenza, Clin. Infect. Dis, 2020.

W. J. Guan, Z. Y. Ni, Y. Hu, W. H. Liang, C. Q. Ou et al., Clinical characteristics of Coronavirus Disease 2019 in China, China Medical Treatment Expert Group for Covid, vol.382, pp.1708-1720, 2020.

I. Hamming, W. Timens, M. L. Bulthuis, A. T. Lely, G. Navis et al., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J. Pathol, vol.203, pp.631-637, 2004.

T. Hashimoto, T. Perlot, A. Rehman, J. Trichereau, H. Ishiguro et al., ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation, Nature, vol.487, pp.477-481, 2012.

J. Helms, S. Kremer, H. Merdji, R. Clere-jehl, M. Schenck et al., Neurologic features in Severe SARS-CoV-2 infection, N. Engl. J. Med, vol.382, pp.2268-2270, 2020.

M. Hoffmann, H. Kleine-weber, S. Schroeder, N. Kr?-uger, T. Herrler et al., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, vol.181, pp.271-280, 2020.

R. Honce and S. Schultz-cherry, Impact of obesity on Influenza A Virus pathogenesis, immune response, and evolution, Front. Immunol, vol.10, pp.1071-1084, 2019.

C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, vol.395, pp.497-506, 2020.

T. Ichinohe, I. K. Pang, Y. Kumamoto, D. R. Peaper, J. H. Ho et al., Microbiota regulates immune defense against respiratory tract influenza A virus infection, Proc. Natl. Acad. Sci. USA, vol.108, pp.5354-5359, 2011.

X. Jin, J. S. Lian, J. H. Hu, J. Gao, L. Zheng et al., Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms, Gut, vol.69, pp.1002-1009, 2020.

S. Kim, K. Rigatto, M. B. Gazzana, M. M. Knorst, E. M. Richards et al., Altered gut microbiome profile in patients with pulmonary arterial hypertension, Hypertension, vol.75, pp.1063-1071, 2020.

K. Kuba, Y. Imai, S. Rao, H. Gao, F. Guo et al., A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat. Med, vol.11, pp.875-879, 2005.

M. M. Lamers, J. Beumer, J. Van-der-vaart, K. Knoops, J. Puschhof et al.,

, SARS-CoV-2 productively infects human gut enterocytes, 2020.

A. Lavelle and H. Sokol, Gut microbiota-derived metabolites as key actors in inflammatory bowel disease, Nat. Rev. Gastroenterol. Hepatol, vol.17, pp.223-237, 2020.

W. Liang, Z. Feng, S. Rao, C. Xiao, X. Xue et al., Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus, Gut, vol.69, pp.1141-1143, 2020.

L. Lin, X. Jiang, Z. Zhang, S. Huang, Z. Zhang et al., Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection, Gut, vol.69, pp.997-1001, 2020.

S. Lukassen, R. L. Chua, T. Trefzer, N. C. Kahn, M. A. Schneider et al., SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells, EMBO J, vol.39, 2020.

R. Mao, Y. Qiu, J. S. He, J. Y. Tan, X. H. Li et al., Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis, Lancet Gastroenterol. Hepatol, vol.5, pp.667-678, 2020.

S. Matsuyama, N. Nagata, K. Shirato, M. Kawase, M. Takeda et al., Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2, J. Virol, vol.84, pp.12658-12664, 2010.

J. A. Mccullers, The co-pathogenesis of influenza viruses with bacteria in the lung, Nat. Rev. Microbiol, vol.12, pp.252-262, 2014.

Y. R. Nobel, M. Phipps, J. Zucker, B. Lebwohl, T. C. Wang et al., Gastrointestinal symptoms and coronavirus disease 2019: a case-control study from the United States, Gastroenterology, 2020.

L. Pan, M. Mu, P. Yang, Y. Sun, R. Wang et al., Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-Sectional, multicenter study, Am. J. Gastroenterol, vol.115, pp.766-773, 2020.

A. Paniz-mondolfi, C. Bryce, Z. Grimes, R. E. Gordon, J. Reidy et al., Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), J. Med. Virol, vol.92, pp.699-702, 2020.

N. Qin, B. Zheng, J. Yao, L. Guo, J. Zuo et al., Influence of H7N9 virus infection and associated treatment on human gut microbiota, Sci. Rep, vol.5, pp.14771-14784, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02638858

R. Ranjbar, M. Shafiee, A. Hesari, G. A. Ferns, F. Ghasemi et al., The potential therapeutic use of renin-angiotensin system inhibitors in the treatment of inflammatory diseases, J. Cell. Physiol, vol.234, pp.2277-2295, 2019.

W. D. Redd, J. C. Zhou, K. E. Hathorn, T. R. Mccarty, A. N. Bazarbashi et al., Prevalence and characteristics of gastrointestinal symptoms in patients with SARS-CoV-2 infection in the United States: A multicenter cohort study, Gastroenterology, 2020.

M. M. Santisteban, S. Kim, C. J. Pepine, and M. K. Raizada, Brain-gutbone marrow axis: Implications for hypertension and related therapeutics, Circ. Res, vol.118, pp.1327-1336, 2016.

V. Sencio, A. Barthelemy, L. P. Tavares, M. G. Machado, D. Soulard et al., Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production, Cell Rep, vol.30, pp.2934-2947, 2020.
URL : https://hal.archives-ouvertes.fr/inserm-02501395

A. K. Singh, R. Gupta, A. Ghosh, and A. Misra, Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations, Diabetes Metab. Syndr, vol.14, pp.303-310, 2020.

R. Singhal and Y. M. Shah, Oxygen battle in the gut: hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine, J. Biol. Chem, 2020.

A. L. Steed, G. P. Christophi, G. E. Kaiko, L. Sun, V. M. Goodwin et al., The microbial metabolite desaminotyrosine protects from influenza through type I interferon, Science, vol.357, pp.498-502, 2017.

S. Sultan, O. Altayar, S. M. Siddique, P. Davitkov, J. D. Feuerstein et al., AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19, 2020.

S. Sun, Q. Chen, H. Gu, G. Yang, Y. Wang et al., A mouse model of SARS-CoV-2 infection and pathogenesis, Cell Host Microbe, 2020.

W. Sungnak, N. Huang, C. Bé-cavin, M. Berg, R. Queen et al., SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, HCA Lung Biological Network, vol.26, pp.681-687, 2020.

A. Trompette, E. S. Gollwitzer, C. Pattaroni, I. C. Lopez-mejia, E. Riva et al., Dietary fiber confers protection against flu by shaping Ly6c À patrolling monocyte hematopoiesis and CD8 + T cell metabolism, Immunity, vol.48, pp.992-1005, 2018.

J. Wang, F. Li, H. Wei, Z. Lian, R. Sun et al., Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J. Exp. Med, vol.211, pp.2397-2410, 2014.

C. Wang, P. W. Horby, F. G. Hayden, and G. F. Gao, A novel coronavirus outbreak of global health concern, Lancet, vol.395, pp.470-473, 2020.

Q. Wang, Y. Zhang, L. Wu, S. Niu, C. Song et al., Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2, Cell, vol.181, pp.894-904, 2020.

D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in, vol.323, pp.1061-1069, 2020.

Z. Wu and J. M. Mcgoogan, Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA, 2020.

F. Xiao, M. Tang, X. Zheng, Y. Liu, X. Li et al., Evidence for gastrointestinal infection of SARS-CoV-2, Gastroenterology, vol.158, pp.1831-1833, 2020.

F. Xiao, J. Sun, Y. Xu, F. Li, X. Huand et al., Infectious SARS-CoV-2 in feces of patient, 2020.

. Emerg, Infect. Dis, vol.26, 2020.

S. Yildiz, B. Mazel-sanchez, M. Kandasamy, B. Manicassamy, and M. Schmolke, Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis, vol.6, pp.9-25, 2018.

L. Yu, Y. Tong, G. Shen, A. Fu, Y. Lai et al., Immunodepletion with hypoxemia: A potential high risk subtype of coronavirus disease, 2019.

R. Zang, M. F. Gomez-castro, B. T. Mccune, Q. Zeng, P. W. Rothlauf et al., TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes, Sci. Immunol, vol.5, p.3582, 2020.

W. Zhang, R. H. Du, B. Li, X. S. Zheng, X. L. Yang et al., Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes, Emerg. Microbes Infect, vol.9, pp.386-389, 2020.

Y. Zhao, Z. Zhao, Y. Wang, Y. Zhou, Y. Ma et al., Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov, 2020.

P. Zhou, X. L. Yang, X. G. Wang, B. Hu, L. Zhang et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, vol.579, pp.270-273, 2020.

Z. Zhou, N. Zhao, Y. Shu, S. Han, B. Chen et al., Effect of gastrointestinal symptoms in patients with COVID-19, Gastroenterology, vol.158, pp.2294-2297, 2020.

J. Zhou, C. Li, X. Liu, M. C. Chiu, X. Zhao et al., Infection of bat and human intestinal organoids by SARS-CoV-2, Nat. Med, p.13, 2020.

N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang et al., A Novel Coronavirus from Patients with Pneumonia in China, China Novel Coronavirus Investigating and Research Team, vol.382, pp.727-733, 2019.

T. Zuo, F. Zhang, G. C. Lui, Y. K. Yeoh, A. Y. Li et al., Alterations in gut microbiota of patients with COVID-19 during time of hospitalization, Gastroenterology, 2020.